Literature DB >> 31161534

Paraneoplastic Cerebellar Degeneration in Nasopharyngeal Carcinoma: a Unique Association.

S Bhardwaj1, S Khasani2, D Benasher3, E G Stein4, T Meghal3, N Jacoby2, Y J Huang3.   

Abstract

Paraneoplastic cerebellar degeneration (PCD) is a rare disorder that is associated with lung or gynecological malignancies and Hodgkin lymphoma. Neurologic symptoms are commonly the initial presenting sign leading to the diagnosis of an underlying malignancy. We are presenting an Asian male with progressive lower extremity weakness with EBV-positive nasopharyngeal carcinoma (NPC) and anti-Yo antibodies. Peculiarly, transient diffuse leptomeningeal enhancement is seen on MR imaging. This is the first report of PCD associated with NPC and thus illustrates that PCD embodies a boarder set of disease than previously described.

Entities:  

Keywords:  Anti-Yo; Autoimmune; Cancer; Cerebellar; Cerebellum; Leptomeningeal; Nasopharyngeal; Neurology; Oncology; Paraneoplastic; Syndrome

Mesh:

Year:  2019        PMID: 31161534     DOI: 10.1007/s12311-019-01045-1

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.648


  13 in total

1.  Unusual MRI abnormalities in anti-Yo positive "pure" paraneoplastic cerebellar degeneration.

Authors:  John C McHugh; Niall Tubridy; Conor D Collins; Michael Hutchinson
Journal:  J Neurol       Date:  2007-11-14       Impact factor: 4.849

2.  Unusual magnetic resonance imaging and cerebrospinal fluid findings in paraneoplastic cerebellar degeneration: a sequential study.

Authors:  C de Andrés; A Esquivel; J G de Villoria; F Graus; S Sánchez-Ramón
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

Review 3.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

4.  Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration.

Authors:  Christopher P Gilmore; Ivo Elliott; Dorothee Auer; Paul Maddison
Journal:  J Neurol       Date:  2009-11-27       Impact factor: 4.849

5.  Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin.

Authors:  J Krakauer; C Balmaceda; J T Gluck; J B Posner; M R Fetell; J Dalmau
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

6.  Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus.

Authors:  I J Sutton; C J Fursdon Davis; M M Esiri; S Hughes; E R Amyes; A Vincent
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

7.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Authors:  Setareh Shams'ili; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Herbert Hooijkaas; Bronno van der Holt; Charles Vecht; Peter Sillevis Smitt
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

8.  Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.

Authors:  J D Debes; S M Lagarde; E Hulsenboom; P A E Sillevis Smitt; F J W ten Kate; G A Sulter; J J B van Lanschot
Journal:  Dig Surg       Date:  2007-08-29       Impact factor: 2.588

Review 9.  Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature.

Authors:  Peter Widdess-Walsh; Jinny O Tavee; Stephan Schuele; Glen H Stevens
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

Review 10.  Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.

Authors:  Anand Venkatraman; Puneet Opal
Journal:  Ann Clin Transl Neurol       Date:  2016-06-30       Impact factor: 4.511

View more
  1 in total

1.  Clinical characteristics of paraneoplastic syndromes in patients with head and neck cancer.

Authors:  Wenwen Diao; Ya Liang; Liming Gao; Yingying Zhu; Xiaoli Zhu; Shuting Yu; Xin Xia; Xingming Chen
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.